VIVIAN KAMAU: Open Payments
NPI 1700472362 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 20 payments from 5 companies in 2025. Trend: 2023 $128 · 2024 $253 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Alkermes, Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
Products named: Auvelity, CAPLYTA, REXULTI, ARISTADA, HETLIOZ.
Industry payments across MD — which companies pay providers there.
